Evidence map›Paper›PMID 27843499›Full record

ArticleMobile DNA2016

Evidence for L1-associated DNA rearrangements and negligible L1 retrotransposition in glioblastoma multiforme.

Patricia E Carreira, Adam D Ewing, Guibo Li, Stephanie N Schauer, Kyle R Upton, Allister C Fagg, Santiago Morell, Michaela Kindlova, Patricia Gerdes, Sandra R Richardson and 5 more

Open access · goldAbstract read
In one paragraph

Article in Mobile DNA, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
9.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 4 countries.

Patricia E Carreira *Mater Research Institute - University of Queensland, TRI Building, Woolloongabba, QLD 4102 Australia.
Adam D Ewing *Mater Research Institute - University of Queensland, TRI Building, Woolloongabba, QLD 4102 Australia.
Guibo Li *BGI-Shenzhen, Shenzhen, 518083 China.
Stephanie N SchauerMater Research Institute - University of Queensland, TRI Building, Woolloongabba, QLD 4102 Australia.
Kyle R UptonMater Research Institute - University of Queensland, TRI Building, Woolloongabba, QLD 4102 Australia.
Allister C FaggMater Research Institute - University of Queensland, TRI Building, Woolloongabba, QLD 4102 Australia.
Santiago MorellMater Research Institute - University of Queensland, TRI Building, Woolloongabba, QLD 4102 Australia.
Michaela KindlovaMater Research Institute - University of Queensland, TRI Building, Woolloongabba, QLD 4102 Australia.
Patricia GerdesMater Research Institute - University of Queensland, TRI Building, Woolloongabba, QLD 4102 Australia.
Sandra R RichardsonMater Research Institute - University of Queensland, TRI Building, Woolloongabba, QLD 4102 Australia.
Bo LiBGI-Shenzhen, Shenzhen, 518083 China.
Daniel J GerhardtMater Research Institute - University of Queensland, TRI Building, Woolloongabba, QLD 4102 Australia.
Jun WangBGI-Shenzhen, Shenzhen, 518083 China.
Paul M BrennanEdinburgh Cancer Research Centre, IGMM, University of Edinburgh, Edinburgh, EH42XR UK.
Geoffrey J FaulknerMater Research Institute - University of Queensland, TRI Building, Woolloongabba, QLD 4102 Australia.
University of Queensland · AUMater Research · AUBGI Group (China) · CNEdinburgh Cancer Research · GBUniversity of Copenhagen · DK

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundLINE-1 (L1) retrotransposons are a notable endogenous source of mutagenesis in mammals. Notably, cancer cells can support unusual L1 retrotransposition and L1-associated sequence rearrangement mechanisms following DNA damage. Recent reports suggest that L1 is mobile in epithelial tumours and neural cells but, paradoxically, not in brain cancers.

resultsHere, using retrotransposon capture sequencing (RC-seq), we surveyed L1 mutations in 14 tumours classified as glioblastoma multiforme (GBM) or as a lower grade glioma. In four GBM tumours, we characterised one probable endonuclease-independent L1 insertion, two L1-associated rearrangements and one likely

conclusionsThese experiments altogether highlight the consistent absence of canonical L1 retrotransposition in GBM tumours and cultured cell lines, as well as atypical L1-associated sequence rearrangements following DNA damage in vivo.

Identifiers

PMID27843499
PMCPMC5105311
OpenAlexW2556847556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.